Decadron Elixir for Oral Treatment of Various Inflammatory and Endocrine Disorders

Decadron is an oral elixir containing dexamethasone, a potent synthetic corticosteroid used to treat a broad range of inflammatory, allergic, endocrine, and neoplastic conditions. It helps reduce inflammation and modulates the immune response in various diseases.

Decadron Elixir is indicated for use in adults and children for the management of multiple conditions, including:

• Endocrine disorders such as primary or secondary adrenocortical insufficiency, congenital adrenal hyperplasia, nonsuppurative thyroiditis, and hypercalcemia related to cancer.
• Rheumatic disorders as adjunctive short-term therapy during acute episodes for diseases including psoriatic arthritis, rheumatoid arthritis (including juvenile type), ankylosing spondylitis, bursitis, tenosynovitis, gouty arthritis, post-traumatic osteoarthritis, synovitis, and epicondylitis.
• Collagen diseases during exacerbations or maintenance therapy for systemic lupus erythematosus and acute rheumatic carditis.
• Dermatologic conditions such as pemphigus, bullous dermatitis herpetiformis, severe erythema multiforme (Stevens-Johnson syndrome), exfoliative dermatitis, mycosis fungoides, severe psoriasis, and severe seborrheic dermatitis.
• Severe allergic states unresponsive to conventional treatments including allergic rhinitis, bronchial asthma, contact and atopic dermatitis, serum sickness, and drug hypersensitivity reactions.
• Ophthalmic inflammatory and allergic conditions involving the eye and its adnexa, such as allergic conjunctivitis, keratitis, corneal ulcers, herpes zoster ophthalmicus, iritis, iridocyclitis, chorioretinitis, anterior segment inflammation, uveitis, optic neuritis, and sympathetic ophthalmia.
• Respiratory diseases including symptomatic sarcoidosis, Loeffler's syndrome, berylliosis, disseminated pulmonary tuberculosis (with proper antituberculous therapy), and aspiration pneumonitis.
• Hematologic disorders such as idiopathic thrombocytopenic purpura, secondary thrombocytopenia, autoimmune hemolytic anemia, erythroblastopenia, and congenital hypoplastic anemia.
• Neoplastic diseases for palliative management of leukemias and lymphomas in adults and acute leukemia in children.
• Edematous states like nephrotic syndrome remission induction.
• Gastrointestinal diseases such as ulcerative colitis and regional enteritis during critical periods.
• Miscellaneous conditions including tuberculous meningitis with subarachnoid block and trichinosis with neurologic or myocardial involvement.
• Diagnostic use in testing for adrenocortical hyperfunction (e.g., dexamethasone suppression tests for Cushing's syndrome).

Dexamethasone

Dexamethasone, the active ingredient in Decadron Elixir, is a synthetic glucocorticoid that mimics naturally occurring corticosteroids produced by the adrenal cortex. It reduces inflammation and suppresses the immune system by modulating the body’s metabolic and immune responses. Unlike natural corticosteroids, dexamethasone has minimal sodium-retaining activity at anti-inflammatory doses.

Dosing must be individualized based on the disease and patient response. The initial oral dose ranges from 0.75 mg to 9 mg per day, depending on severity; lower doses may be sufficient for milder conditions and higher doses may be required for more severe diseases. Maintenance doses should be carefully titrated downward to the lowest effective dose after clinical improvement. Dose adjustments may be necessary during stress such as surgery or infection. If treatment extends beyond a few days, gradual withdrawal is recommended to avoid adrenal insufficiency.

For dexamethasone suppression testing in Cushing’s syndrome diagnosis, specific oral doses and timing protocols are used, such as 1 mg orally at 11 p.m. with cortisol measured the next morning, or multiple doses over 48 hours for greater accuracy.

Conversion from other corticosteroids: 0.75 mg dexamethasone is approximately equivalent to 4 mg methylprednisolone or triamcinolone, 5 mg prednisolone or prednisone, 20 mg hydrocortisone, and 25 mg cortisone.

Decadron Elixir is contraindicated in patients with systemic fungal infections and in those with known hypersensitivity to any component of the product.

Important safety considerations with Decadron Elixir include:

• Patients on corticosteroids undergoing unusual physiological stress (e.g., surgery, trauma) may require increased corticosteroid doses.
• Abrupt withdrawal can cause secondary adrenal insufficiency; taper slowly after extended therapy.
• Corticosteroids may mask infections and decrease resistance to new infections; latent infections such as tuberculosis, amebiasis, and others should be ruled out before treatment.
• Use in active or latent tuberculosis is restricted and requires concurrent antituberculous therapy.
• Prolonged use can cause eye complications including posterior subcapsular cataracts, glaucoma, and secondary infections.
• Use cautiously in patients with recent myocardial infarction due to risk of ventricular rupture.
• Immunosuppressive doses contraindicate live virus vaccines; antibody response to inactivated vaccines may be reduced.
• Patients should avoid exposure to chickenpox and measles, as these infections can be severe or fatal in immunosuppressed individuals.
• Monitor and manage potential electrolyte imbalances; corticosteroids may cause sodium retention, potassium loss, hypertension, and require salt restriction or potassium supplementation.
• Potential psychiatric disturbances may occur, including mood changes and psychosis.

Common and serious side effects reported with dexamethasone use include:

• Fluid and electrolyte disturbances: sodium retention, potassium loss, fluid retention, hypokalemic alkalosis, hypertension, congestive heart failure in susceptible patients.
• Musculoskeletal: muscle weakness, steroid myopathy, osteoporosis, pathologic fractures (including aseptic necrosis), tendon rupture.
• Gastrointestinal: pancreatitis, ulcerative esophagitis, bowel perforation, peptic ulcer with hemorrhage.
• Dermatologic: impaired wound healing, thin fragile skin, petechiae, ecchymoses, increased sweating, allergic dermatitis.
• Neurologic: convulsions, increased intracranial pressure, vertigo, headache.
• Psychic disturbances: mood swings, insomnia, euphoria, severe depression, psychosis.
• Endocrine: menstrual irregularities, Cushingoid state, growth suppression in children, diabetes mellitus exacerbation, adrenal insufficiency during stress.
• Ophthalmic: cataracts, glaucoma, increased intraocular pressure, exophthalmos.
• Metabolic/Cardiovascular: negative nitrogen balance, myocardial rupture post infarction reported.
• Other: hypersensitivity reactions, nausea, thromboembolism, weight gain, increased appetite, hiccups.

Dexamethasone interacts with various medications:

• Drugs like phenytoin, phenobarbital, ephedrine, and rifampin may increase corticosteroid metabolism, lowering blood levels and potentially requiring dose adjustment.
• Indomethacin may cause false-negative results in dexamethasone suppression tests.
• Concurrent use with coumarin anticoagulants can alter prothrombin time; frequent monitoring is advised.
• Potassium-depleting diuretics used with corticosteroids increase the risk of hypokalemia and require close monitoring.
• Live virus vaccines are contraindicated during immunosuppressive corticosteroid therapy; antibody response to inactivated vaccines may be reduced.

Use of dexamethasone during pregnancy requires careful benefit-risk assessment, as adequate studies in humans are lacking. Newborns of mothers treated with corticosteroids should be monitored for adrenal insufficiency. Dexamethasone is excreted in breast milk and may suppress infant growth and adrenal function; nursing is not recommended for mothers receiving pharmacologic doses.

Reports of acute overdose are rare. In case of overdose, treatment is supportive and symptomatic; no specific antidote is available.

Store Decadron Elixir at controlled room temperature, 20°C to 25°C (68°F to 77°F). Keep the bottle tightly closed and avoid freezing. Dispense in a tight container as per USP standards.